Cinnamic acid and lactobionic acid based nanoformulations as a potential antiamoebic therapeutics.

[1]  R. Siddiqui,et al.  Nanovesicles containing curcumin hold promise in the development of new formulations of anti-Acanthamoebic agents. , 2021, Molecular and biochemical parasitology.

[2]  L. Weaver,et al.  High oxygen concentrations inhibit Acanthamoeba spp. , 2021, Parasitology Research.

[3]  M. Khamis,et al.  Cationic Surfactant–Natural Clay Complex as a Novel Agent Against Acanthamoeba castellanii Belonging to the T4 Genotype , 2021, Eye & contact lens.

[4]  J. McKerrow,et al.  Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs , 2021, Expert review of anti-infective therapy.

[5]  J. Lorenzo-Morales,et al.  In vitro amoebicidal effects of arabinogalactan-based ophthalmic solution , 2021, International journal for parasitology. Drugs and drug resistance.

[6]  R. Siddiqui,et al.  Development of anti-acanthamoebic approaches , 2021, International Microbiology.

[7]  J. Lorenzo-Morales,et al.  In vitro validation of the amoebicidal activity of commercial eye drops as second activity , 2021, International journal for parasitology. Drugs and drug resistance.

[8]  A. Elhissi,et al.  Galactosylated iron oxide nanoparticles for enhancing oral bioavailability of ceftriaxone , 2021, Pharmaceutical development and technology.

[9]  N. Durán,et al.  New Sustainable Process for Hesperidin Isolation and Anti-Ageing Effects of Hesperidin Nanocrystals , 2020, Molecules.

[10]  Ayaz Anwar,et al.  Metronidazole conjugated magnetic nanoparticles loaded with amphotericin B exhibited potent effects against pathogenic Acanthamoeba castellanii belonging to the T4 genotype , 2020, AMB Express.

[11]  B. Malaekeh-Nikouei,et al.  The role of nanotechnology in combating biofilm-based antibiotic resistance , 2020 .

[12]  S. Bonini,et al.  Acanthamoeba Keratitis: Perspectives for Patients , 2020, Current eye research.

[13]  B. Ankamwar,et al.  A Review on Antimicrobial Properties of Metal Nanoparticles. , 2020, Journal of nanoscience and nanotechnology.

[14]  A. Elhissi,et al.  Enhancement in Oral Absorption of Ceftriaxone by Highly Functionalized Magnetic Iron Oxide Nanoparticles , 2020, Pharmaceutics.

[15]  R. Siddiqui,et al.  Antibacterial Activities of Selected Pure Compounds Isolated from Gut Bacteria of Animals Living in Polluted Environments , 2020, Antibiotics.

[16]  J. McKerrow,et al.  The Antifungal Drug Isavuconazole Is both Amebicidal and Cysticidal against Acanthamoeba castellanii , 2020, Antimicrobial Agents and Chemotherapy.

[17]  G. Sethi,et al.  Molecular mechanisms of action of hesperidin in cancer: Recent trends and advancements , 2020, Experimental biology and medicine.

[18]  M. R. Shah,et al.  Antiamoebic activity of plant-based natural products and their conjugated silver nanoparticles against Acanthamoeba castellanii (ATCC 50492) , 2020, AMB Express.

[19]  G. Amaratunga,et al.  Graphene oxide based nano-composite for sustained release of cephalexin. , 2020, Journal of pharmaceutical sciences.

[20]  W. Sullivan,et al.  Repositioning of guanabenz in conjugation with gold and silver nanoparticles against pathogenic amoebae Acanthamoeba castellanii and Naegleria fowleri. , 2019, ACS infectious diseases.

[21]  R. Siddiqui,et al.  Gut Bacteria of Water Monitor Lizard (Varanus salvator) Are a Potential Source of Antibacterial Compound(s) , 2019, Antibiotics.

[22]  A. Tsatsakis,et al.  Cardioprotective effects of hesperidin on carbon monoxide poisoned in rats , 2019, Drug and chemical toxicology.

[23]  Mohammad Khalid,et al.  Cobalt nanoparticles as novel nanotherapeutics against Acanthamoeba castellanii , 2019, Parasites & Vectors.

[24]  Z. Kong,et al.  Curcumin-Loaded Mesoporous Silica Nanoparticles Markedly Enhanced Cytotoxicity in Hepatocellular Carcinoma Cells , 2019, International journal of molecular sciences.

[25]  A. Mahmoud,et al.  Beneficial Effects of Citrus Flavonoids on Cardiovascular and Metabolic Health , 2019, Oxidative medicine and cellular longevity.

[26]  J. van Griensven,et al.  Visceral Leishmaniasis: Recent Advances in Diagnostics and Treatment Regimens. , 2019, Infectious disease clinics of North America.

[27]  K. Rajendran,et al.  Antimicrobial activities of green synthesized gums-stabilized nanoparticles loaded with flavonoids , 2019, Scientific Reports.

[28]  Naveen Samuel Singh,et al.  A Review on Major Risk Factors and Current Status of Visceral Leishmaniasis in North India , 2019, American Journal of Entomology.

[29]  M. Morales,et al.  Aggregation effects on the magnetic properties of iron oxide colloids , 2019, Nanotechnology.

[30]  B. Seitz,et al.  Acanthamoeba keratitis – Clinical signs, differential diagnosis and treatment , 2018, Journal of current ophthalmology.

[31]  D. K. Majumdar,et al.  Design, characterization, and evaluation of aceclofenac-loaded Eudragit RS 100 nanoparticulate system for ocular delivery , 2018, Pharmaceutical development and technology.

[32]  S. Paul,et al.  Antifungal activity of curcumin-silver nanoparticles against fluconazole-resistant clinical isolates of Candida species , 2018, Ayu.

[33]  E. Morii,et al.  A case report of granulomatous amoebic encephalitis by Group 1 Acanthamoeba genotype T18 diagnosed by the combination of morphological examination and genetic analysis , 2018, Diagnostic Pathology.

[34]  M. R. Shah,et al.  Gum acacia stabilized silver nanoparticles based nano-cargo for enhanced anti-arthritic potentials of hesperidin in adjuvant induced arthritic rats , 2018, Artificial cells, nanomedicine, and biotechnology.

[35]  Ayaz Anwar,et al.  Silver nanoparticle conjugation affects antiacanthamoebic activities of amphotericin B, nystatin, and fluconazole , 2017, Parasitology Research.

[36]  Zhengyu Jin,et al.  Linear dextrin as curcumin delivery system: Effect of degree of polymerization on the functional stability of curcumin , 2017 .

[37]  Meijia Wu,et al.  Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment. , 2017, Molecular and clinical oncology.

[38]  R. Bucki,et al.  Use of magnetic nanoparticles as a drug delivery system to improve chlorhexidine antimicrobial activity , 2017, International journal of nanomedicine.

[39]  Ayaz Anwar,et al.  Future Priorities in Tackling Infections Due to Brain-Eating Amoebae. , 2017, ACS chemical neuroscience.

[40]  A. El-Karef,et al.  Hepatoprotective effect of hesperidin in hepatocellular carcinoma: Involvement of Wnt signaling pathways , 2017, Life sciences.

[41]  M. Natan,et al.  From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance. , 2017, FEMS microbiology reviews.

[42]  A. López-Arencibia,et al.  Amoebicidal Activity of Caffeine and Maslinic Acid by the Induction of Programmed Cell Death in Acanthamoeba , 2017, Antimicrobial Agents and Chemotherapy.

[43]  Naveed Ahmed Khan,et al.  Pathogenesis of microbial keratitis. , 2017, Microbial pathogenesis.

[44]  L. Shao,et al.  The antimicrobial activity of nanoparticles: present situation and prospects for the future , 2017, International journal of nanomedicine.

[45]  H. Tenhu,et al.  Size, Stability, and Porosity of Mesoporous Nanoparticles Characterized with Light Scattering , 2017, Nanoscale Research Letters.

[46]  Gareth R Williams,et al.  Lactobionic acid and carboxymethyl chitosan functionalized graphene oxide nanocomposites as targeted anticancer drug delivery systems. , 2016, Carbohydrate polymers.

[47]  L. Gonçalves,et al.  NANOBIOCATALYTIC SYSTEMS BASED ON LIPASE-Fe3O4 AND CONVENTIONAL SYSTEMS FOR ISONIAZID SYNTHESIS: A COMPARATIVE STUDY , 2016 .

[48]  Marisa Papaluca,et al.  Nanomedicines in the EU—Regulatory Overview , 2016, The AAPS Journal.

[49]  A. Elhissi,et al.  Glycoside-based niosomal nanocarrier for enhanced in-vivo performance of Cefixime. , 2016, International journal of pharmaceutics.

[50]  V. Rotello,et al.  Nanoparticle-Based Antimicrobials: Surface Functionality is Critical , 2016, F1000Research.

[51]  F. Stapleton,et al.  Strategies for the prevention of contact lens‐related Acanthamoeba keratitis: a review , 2016, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

[52]  S. Das,et al.  Antibacterial Effects of Biosynthesized Silver Nanoparticles on Surface Ultrastructure and Nanomechanical Properties of Gram-Negative Bacteria viz. Escherichia coli and Pseudomonas aeruginosa. , 2016, ACS applied materials & interfaces.

[53]  Damien Mertz,et al.  Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents. , 2016, Nanoscale.

[54]  Bibekanand Mallick,et al.  Antimicrobial activity of iron oxide nanoparticle upon modulation of nanoparticle-bacteria interface , 2015, Scientific Reports.

[55]  P. Mutlu,et al.  Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[56]  Surinder P. Singh,et al.  The role of nanotechnology in combating multi-drug resistant bacteria. , 2014, Journal of nanoscience and nanotechnology.

[57]  P. Scheid,et al.  First report of an Acanthamoeba genotype T13 isolate as etiological agent of a keratitis in humans , 2014, Parasitology Research.

[58]  M. T. Wong,et al.  Mechanisms of antibacterial activity of MgO: non-ROS mediated toxicity of MgO nanoparticles towards Escherichia coli. , 2014, Small.

[59]  Rong-Kun Chang,et al.  Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems. , 2013, Journal of pharmaceutical sciences.

[60]  M. Sharifdini,et al.  Pathogenic Assays of Acanthamoeba Belonging to the T4 Genotype , 2013, Iranian journal of parasitology.

[61]  A. López-Arencibia,et al.  Acanthamoeba keratitis: an emerging disease gathering importance worldwide? , 2013, Trends in parasitology.

[62]  Dik van de Meent,et al.  Considerations on the EU definition of a nanomaterial: science to support policy making. , 2013, Regulatory toxicology and pharmacology : RTP.

[63]  Vladimir P. Torchilin,et al.  Challenges in Development of Targeted Liposomal Therapeutics , 2012, The AAPS Journal.

[64]  Naveed Ahmed Khan,et al.  Biology and pathogenesis of Acanthamoeba , 2012, Parasites & Vectors.

[65]  Vivek Dhawan,et al.  Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administration. , 2011, Molecular pharmaceutics.

[66]  Rupesh Kumar Basniwal,et al.  Curcumin nanoparticles: preparation, characterization, and antimicrobial study. , 2011, Journal of agricultural and food chemistry.

[67]  Jyh-Ping Chen,et al.  Characterization of chitosan magnetic nanoparticles for in situ delivery of tissue plasminogen activator , 2011 .

[68]  Basilio Valladares,et al.  The potential pathogenicity of chlorhexidine-sensitive Acanthamoeba strains isolated from contact lens cases from asymptomatic individuals in Tenerife, Canary Islands, Spain. , 2008, Journal of medical microbiology.

[69]  N. Khan,et al.  The role of proteases in the differentiation of Acanthamoeba castellanii. , 2008, FEMS microbiology letters.

[70]  Yong-mei Li,et al.  In vivo pharmacokinetics of hesperidin are affected by treatment with glucosidase-like BglA protein isolated from yeasts. , 2008, Journal of agricultural and food chemistry.

[71]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[72]  K. Kim,et al.  Balamuthia mandrillaris interactions with human brain microvascular endothelial cells in vitro. , 2007, Journal of medical microbiology.

[73]  Yongmin Chang,et al.  Surface modification of magnetite nanoparticles using lactobionic acid and their interaction with hepatocytes. , 2007, Biomaterials.

[74]  P. Cullis,et al.  Drug Delivery Systems: Entering the Mainstream , 2004, Science.

[75]  J. Pérez-Santonja,et al.  Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity. , 2003, Ophthalmology.

[76]  J. Bessière,et al.  The essential oils of Rinorea subintegrifolia O. Ktze and Drypetes gossweileri S. Moore occurring in Gabon , 2003 .

[77]  S. Sarker,et al.  Pyranoisoflavones from Rinorea welwitschii. , 2000, Fitoterapia.

[78]  A. Ghidan,et al.  Exploration of Antioxidant, Antibacterial Activities of Green Synthesized Hesperidin Loaded PLGA Nanoparticles , 2021, Biointerface Research in Applied Chemistry.

[79]  S. Srinivasan,et al.  Antidiabetic Efficacy of Citrus Fruits With Special Allusion to Flavone Glycosides , 2019, Bioactive Food as Dietary Interventions for Diabetes.

[80]  H. K. Manjili,et al.  Anticancer Activity of Tamoxifen Loaded Tyrosine Decorated Biocompatible Fe3O4 Magnetic Nanoparticles Against Breast Cancer Cell Lines , 2017, Journal of Inorganic and Organometallic Polymers and Materials.

[81]  S. Lata,et al.  ROLE OF NANOTECHNOLOGY IN DRUG DELIVERY , 2017 .

[82]  Mukta Bhatele,et al.  A Brief Review on Role of Nanotechnology in Medical Sciences , 2013 .

[83]  P. Cullis,et al.  Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.

[84]  C. Bunce,et al.  Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. , 2008, American journal of ophthalmology.

[85]  Myung‐Sook Choi,et al.  Interactive effect of hesperidin and vitamin E supplements on cholesterol metabolism in high cholesterol-fed rats. , 2001, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[86]  Y. Barenholz,et al.  Annals of the New York Academy of Sciences Nanomedicines: Addressing the Scientific and Regulatory Gap , 2022 .